Africa (WHO region) vs Grenada: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Grenada
100.0%
in 2019
Africa (WHO region) rank
2nd
Grenada rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Grenada
How they compare
Grenada currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 5 years both countries report, Grenada has been ahead every year.
Africa (WHO region) ranks 2nd and Grenada ranks 1st of 11 groups.
Grenada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 100.0% | 67.0% | Grenada |
| 2010s | 88.3% | 100.0% | 11.7% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Grenada?
- Grenada, at 100.0% against 96.0% in Africa (WHO region) as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Grenada?
- 4.0%, with Grenada ahead.
- How many years of comparable data are there for Africa (WHO region) and Grenada?
- 5 years are reported by both, from 2008 to 2019.
- How do Africa (WHO region) and Grenada rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Grenada ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.